Works matching IS 20406207 AND DT 2019 AND VI 10
Results: 34
Daratumumab in untreated newly diagnosed multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719894871
- By:
- Publication type:
- Article
Biomarkers in acute graft- versus -host disease: new insights.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719891358
- By:
- Publication type:
- Article
Emerging treatment options for patients with p53-pathway-deficient CLL.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719891356
- By:
- Publication type:
- Article
Stem-cell transplantation in multiple myeloma: how far have we come?
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719888111
- By:
- Publication type:
- Article
High factor VIII levels and arterial thrombosis: illustrative case and literature review.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719886685
- By:
- Publication type:
- Article
Venetoclax for the treatment of newly diagnosed acute myeloid leukemia in patients who are ineligible for intensive chemotherapy.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719882822
- By:
- Publication type:
- Article
Allogeneic transplant for FLT3 - ITD mutated AML: a focus on FLT3 inhibitors before, during, and after transplant.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719882666
- By:
- Publication type:
- Article
Autologous hematopoietic stem-cell transplant in small-sized and peripheral centers: a 10-year experiment.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719879587
- By:
- Publication type:
- Article
Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719874733
- By:
- Publication type:
- Article
Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719874728
- By:
- Publication type:
- Article
Novel insights into the treatment of complement-mediated hemolytic anemias.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719873321
- By:
- Publication type:
- Article
Updates in the management of polycythemia vera and essential thrombocythemia.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719870052
- By:
- Publication type:
- Article
Insights into novel emerging epigenetic drugs in myeloid malignancies.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719866081
- By:
- Publication type:
- Article
Role of oral anticoagulant therapy for secondary prevention in patients with stable atherothrombotic disease manifestations.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719861475
- By:
- Publication type:
- Article
Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719860645
- By:
- Publication type:
- Article
Management of perioperative hemostasis in a severe hemophilia A patient with inhibitors on emicizumab using global hemostasis assays.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719860025
- By:
- Publication type:
- Article
Efficacy and safety of simoctocog alfa (Nuwiq®) in patients with severe hemophilia A: a review of clinical trial data from the GENA program.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719858471
- By:
- Publication type:
- Article
Chronic myelomonocytic leukemia associated with myeloid sarcomas and NPM1 mutation: a case report and literature review.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719854596
- By:
- Publication type:
- Article
Current and emerging immunotherapeutic approaches to the treatment of multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719854171
- By:
- Publication type:
- Article
Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719849496
- By:
- Publication type:
- Article
Management of myelodysplastic syndromes after failure of response to hypomethylating agents.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719847059
- By:
- Publication type:
- Article
Immune targeting of the microenvironment in classical Hodgkin's lymphoma: insights for the hematologist.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719846451
- By:
- Publication type:
- Article
Update on the role of venetoclax and rituximab in the treatment of relapsed or refractory CLL.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719844697
- By:
- Publication type:
- Article
Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719841735
- By:
- Publication type:
- Article
The role of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719841591
- By:
- Publication type:
- Article
CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719841581
- By:
- Publication type:
- Article
Cost of peripheral neuropathy in patients receiving treatment for multiple myeloma: a US administrative claims analysis.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719839025
- By:
- Publication type:
- Article
Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719837906
- By:
- Publication type:
- Article
Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719827310
- By:
- Publication type:
- Article
Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemia.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620719826444
- By:
- Publication type:
- Article
Immunotherapy in myeloma: how far have we come?
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620718822660
- By:
- Publication type:
- Article
Novel treatment approaches and future perspectives in follicular lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620718820510
- By:
- Publication type:
- Article
A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology setting.
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620718816699
- By:
- Publication type:
- Article
Epigenetic therapy combinations in acute myeloid leukemia: what are the options?
- Published in:
- Therapeutic Advances in Hematology, 2019, v. 10, p. 1, doi. 10.1177/2040620718816698
- By:
- Publication type:
- Article